From Discovery to Therapy
Image
When
5 – 6:30 p.m., May 7, 2026
The therapy development pipeline is changing. Large pharma is now leaving it to small biotech to fill the void of early-stage biomedical research. Learn how U of A's Center for Advanced Molecular and Immunological Therapies (CAMI) is using an innovative entrepreneurial model of taking new discoveries in academia into early-phase therapies ready for commercialization to bring personalized Immunotherapies to all Arizonans.
Featuring Associate Research Professor and Associate Director of CAMI Ryan Sprissler.
Image
